PL394605A1 - Trwała złożona kompozycja farmaceutyczna - Google Patents

Trwała złożona kompozycja farmaceutyczna

Info

Publication number
PL394605A1
PL394605A1 PL394605A PL39460509A PL394605A1 PL 394605 A1 PL394605 A1 PL 394605A1 PL 394605 A PL394605 A PL 394605A PL 39460509 A PL39460509 A PL 39460509A PL 394605 A1 PL394605 A1 PL 394605A1
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
stable complex
complex pharmaceutical
stable
composition
Prior art date
Application number
PL394605A
Other languages
English (en)
Inventor
László Wagner
Zsolt Zsigmond
György Ujfalussy
Huszár Magdolna Leventiszné
Péter Tonka-Nagy
Erzsébet Bárczay
Lászlóné Góra
Edit Szeleczki
Ágnes Fülöp
Original Assignee
Egis Gyógyszergyár Nyilvánosan Múködö
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyógyszergyár Nyilvánosan Múködö filed Critical Egis Gyógyszergyár Nyilvánosan Múködö
Publication of PL394605A1 publication Critical patent/PL394605A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Packages (AREA)
PL394605A 2008-09-30 2009-09-30 Trwała złożona kompozycja farmaceutyczna PL394605A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0800591A HU230877B1 (hu) 2008-09-30 2008-09-30 Stabil kombinációs gyógyszerkészítmény

Publications (1)

Publication Number Publication Date
PL394605A1 true PL394605A1 (pl) 2011-09-26

Family

ID=89988527

Family Applications (3)

Application Number Title Priority Date Filing Date
PL09748467T PL2344141T3 (pl) 2008-09-30 2009-09-30 Kompozycje zawierające amlodypinę i bisoprolol
PL394605A PL394605A1 (pl) 2008-09-30 2009-09-30 Trwała złożona kompozycja farmaceutyczna
PL11003486T PL2359815T3 (pl) 2008-09-30 2009-09-30 Kompozycje zawierające amlodypinę i bisoprolol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL09748467T PL2344141T3 (pl) 2008-09-30 2009-09-30 Kompozycje zawierające amlodypinę i bisoprolol

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL11003486T PL2359815T3 (pl) 2008-09-30 2009-09-30 Kompozycje zawierające amlodypinę i bisoprolol

Country Status (31)

Country Link
EP (2) EP2344141B1 (pl)
KR (1) KR101772619B1 (pl)
CN (1) CN102164585B (pl)
AT (2) AT510866A3 (pl)
BG (1) BG66274B1 (pl)
CH (1) CH702345B1 (pl)
CY (1) CY1122084T1 (pl)
CZ (2) CZ308237B6 (pl)
DE (1) DE202009019152U1 (pl)
DK (1) DK2344141T3 (pl)
EA (2) EA038392B1 (pl)
EE (1) EE05723B1 (pl)
ES (2) ES2385988B2 (pl)
GE (1) GEP20135859B (pl)
HK (1) HK1155976A1 (pl)
HR (3) HRP20110162B1 (pl)
HU (3) HU230877B1 (pl)
LT (3) LT2344141T (pl)
ME (1) ME03774B (pl)
MX (1) MX2011003407A (pl)
MY (1) MY175270A (pl)
PL (3) PL2344141T3 (pl)
PT (3) PT2344141T (pl)
RO (1) RO127490B1 (pl)
RS (3) RS59201B1 (pl)
RU (2) RU2687282C2 (pl)
SG (1) SG194392A1 (pl)
SI (2) SI2344141T1 (pl)
SK (2) SK288593B6 (pl)
UA (1) UA101407C2 (pl)
WO (1) WO2010038091A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230877B1 (hu) 2008-09-30 2018-11-29 EGIS Gyógyszergyár NyR Stabil kombinációs gyógyszerkészítmény
CN101766611B (zh) * 2010-02-09 2011-10-12 施慧达药业集团(吉林)有限公司 一种左旋氨氯地平或其可药用盐和β受体阻滞剂的药物组合物及其应用
US20150094345A1 (en) 2012-02-17 2015-04-02 Egis Gyogyszergyar Zrt. Pharmaceutical formulation having improved stability
SG11201509998WA (en) * 2013-06-13 2016-01-28 Akebia Therapeutics Inc Compositions and methods for treating anemia
HUP1300496A2 (hu) 2013-08-16 2015-03-02 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Stabil kombinációs gyógyszerkészítmény
FR3027803B1 (fr) * 2014-11-05 2018-02-09 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant et un inhibiteur de l'enzyme de conversion
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
WO2024052498A1 (en) 2022-09-07 2024-03-14 Kinast Lasse An immediate-release oral pharmaceutical form of amlodipine with increased api content
CN116687926B (zh) * 2023-07-27 2023-12-12 石家庄四药有限公司 一种比索洛尔氨氯地平复方片剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU221810B1 (hu) * 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
CA2433181C (en) 2000-12-29 2005-11-22 Pfizer Limited Amlodipine hemifumarate
AT5874U1 (de) * 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
AU2001100431A4 (en) * 2001-10-03 2001-11-01 Pfizer Limited Pharmaceutical compositions comprising amlodipine maleate
WO2003032954A1 (en) 2001-10-17 2003-04-24 Dr. Reddy's Laboratories Ltd. Stabilized pharmaceutical formulations containing amlodipine maleate
WO2004075825A2 (en) * 2003-02-28 2004-09-10 Ranbaxy Laboratories Limited Dosage forms of amlodipine and processes for their preparation
WO2005051350A2 (en) * 2003-10-28 2005-06-09 Torrent Pharmaceuticals Limited Water dispersible tablet
WO2005099699A1 (en) * 2004-04-07 2005-10-27 Sepracor Inc. Combination of (s)-amlodipine and a beta-blocker, and methods for reducing hypertension
IN224215B (pl) 2004-08-05 2009-02-06
WO2006059217A1 (en) * 2004-12-01 2006-06-08 Ranbaxy Laboratories Limited Stable solid dosage forms of amlodipine besylate and processes for their preparation
CZ2005141A3 (cs) * 2005-03-07 2006-04-12 Lunaria, Spol. S. R. O. Lécivý prípravek na bázi amlodipin-besilátu se zvýsenou stabilitou
IES20070122A2 (en) * 2006-12-05 2008-05-28 Michael Hilary Burke A process for the preparation of an orally administered unit dose tablet
HU230877B1 (hu) 2008-09-30 2018-11-29 EGIS Gyógyszergyár NyR Stabil kombinációs gyógyszerkészítmény

Also Published As

Publication number Publication date
KR101772619B1 (ko) 2017-08-29
HUP0800591A2 (en) 2010-10-28
EP2344141A2 (en) 2011-07-20
RO127490A2 (ro) 2012-06-29
RU2549437C2 (ru) 2015-04-27
RU2014139476A (ru) 2015-06-20
RS60784B1 (sr) 2020-10-30
EP2359815A1 (en) 2011-08-24
HUE049948T2 (hu) 2020-11-30
SG194392A1 (en) 2013-11-29
PT2010038091Y (pt) 2020-02-10
WO2010038091A9 (en) 2011-04-07
RS59201B1 (sr) 2019-10-31
HRP20110162A8 (hr) 2019-03-22
CZ2011252A3 (cs) 2011-07-07
CZ308237B6 (cs) 2020-03-18
EA026238B1 (ru) 2017-03-31
LT2344141T (lt) 2019-08-26
ME03774B (me) 2021-04-20
EA201100430A1 (ru) 2011-10-31
SI2344141T1 (sl) 2019-09-30
PL2344141T3 (pl) 2019-10-31
RU2011112047A (ru) 2012-11-10
EP2344141B1 (en) 2019-05-01
HUE045326T2 (hu) 2019-12-30
PT2359815T (pt) 2020-04-16
HU230877B1 (hu) 2018-11-29
SK288593B6 (sk) 2018-09-03
HRP20191373T1 (hr) 2019-11-01
EA038392B1 (ru) 2021-08-20
SK50232011A3 (sk) 2011-08-04
AT510866A2 (de) 2012-07-15
CN102164585A (zh) 2011-08-24
BG66274B1 (bg) 2012-12-28
SK72017U1 (sk) 2017-08-02
CN102164585B (zh) 2016-04-27
HRP20200614T1 (hr) 2020-10-02
AT510866A3 (de) 2014-06-15
EP2359815B1 (en) 2020-01-08
EE201100029A (et) 2011-06-15
MX2011003407A (es) 2011-06-20
EA026238B9 (ru) 2017-05-31
PL2359815T3 (pl) 2020-11-30
WO2010038091A3 (en) 2010-09-23
RU2687282C2 (ru) 2019-05-13
PT2344141T (pt) 2019-08-06
HRP20110162B1 (hr) 2019-09-20
SI2359815T1 (sl) 2020-10-30
HU0800591D0 (en) 2008-11-28
ES2739900T3 (es) 2020-02-04
LT2359815T (lt) 2020-04-27
DE202009019152U1 (de) 2017-03-06
UA101407C2 (ru) 2013-03-25
CY1122084T1 (el) 2020-11-25
AT14769U1 (de) 2016-05-15
RS20110136A1 (en) 2012-08-31
EA201691869A1 (ru) 2017-04-28
MY175270A (en) 2020-06-17
EE05723B1 (et) 2014-10-15
RS60686B1 (sr) 2020-09-30
LT2011012A (lt) 2011-10-25
CZ30825U1 (cs) 2017-07-11
DK2344141T3 (da) 2019-08-05
LT5815B (lt) 2012-02-27
CH702345B1 (de) 2014-05-15
RO127490B1 (ro) 2022-01-28
SK7997Y1 (sk) 2018-02-05
BG110927A (bg) 2011-09-30
ES2385988B2 (es) 2013-12-11
KR20110063563A (ko) 2011-06-10
HK1155976A1 (zh) 2012-06-01
HRP20110162A2 (hr) 2011-06-30
ES2385988A1 (es) 2012-08-06
GEP20135859B (en) 2013-06-25
WO2010038091A2 (en) 2010-04-08

Similar Documents

Publication Publication Date Title
IL228817A0 (en) Pharmaceutical compounds
EP2240022A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0814695D0 (en) Pharmaceutical compositions
EP2373681A4 (en) PHARMACEUTICAL COMPOSITIONS
EP2133095A4 (en) PHARMACEUTICAL COMPOSITION
EP2133094A4 (en) PHARMACEUTICAL COMPOSITION
EP2191826A4 (en) PHARMACEUTICAL COMPOSITION
PL2323623T3 (pl) Kompozycje farmaceutyczne
EP2236149A4 (en) MEDICAL COMPOSITION
EP2224805A4 (en) PHARMACEUTICAL COMPOSITION
ZA201102715B (en) Solid pharmaceutical composition
PL394605A1 (pl) Trwała złożona kompozycja farmaceutyczna
IL208387A0 (en) Pharmaceutical composition
EP2306998A4 (en) PHARMACEUTICAL FORMULATION
EP2116241A4 (en) PHARMACEUTICAL COMPOSITION
ZA201100871B (en) Solid pharmaceutical composition
EP2156832A4 (en) PHARMACEUTICAL COMPOSITION
ZA201006224B (en) Pharmaceutical composition
EP2327406A4 (en) STABILIZED PHARMACEUTICAL COMPOSITION
EP2224806A4 (en) PHARMACEUTICAL COMPOSITION
GB2464200B (en) Pharmaceutical composition
GB0817969D0 (en) Pharmaceutical composition
IL206487A0 (en) Pharmaceutical compositions
HK1182939A1 (en) Stable pharmaceutical composition
GB0800659D0 (en) Pharmaceutical Compositions